Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure
Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure have?
Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure has 139 citations in the OpenAlex counts ScholarIQ stores.
When was Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure published?
Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure has 2014 year in the ScholarIQ index.
What is the open-access status of Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure?
Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure has bronze oa status in the ScholarIQ index.
What is the DOI of Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure?
The DOI for Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure is on the source record.
What is the PMID of Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure?
The PMID for Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure is on the source record.
What is the OpenAlex record for Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure?
The OpenAlex for Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure is on the source record.